The influential advisory firm reported Mr. Dvorak’s total compensation climbed more than 50 percent to $12 million last year, despite a 9.2 percent decline in Zimmer shares. Stock options awards and increases in the value of restricted stock were cited as the biggest factors behind his increased total compensation, according to the news report.
Zimmer fired back saying ISS “significantly overstates” Mr. Dvorak’s executive compensation. According to the medical device company, the CEO’s total compensation in 2010 clocked in at $9.6 million, and two other advisory firms have already supported a shareholder vote for the non-binding executive pay proposal, according to the news report.
Read the news report about Zimmer Holdings CEO David Dvorak’s compensation.
Read other coverage about Zimmer Holdings:
– Zimmer Holdings Reports 3Q Net Sales at $965M, a 1.1% Decrease
– Zimmer Holdings Acquires SoPlus Orthopaedic Surgical Power Tools
– Zimmer Holdings Attracts Investor Attention
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
